IQVIA Holdings, Inc. Common Stock (NY:IQV)

258.11 -1.87 (-0.72%)

Official Closing Price Updated: 7:00 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Earnings Outlook For IQVIA Holdings ↗

February 09, 2023

Via Benzinga

3 Revolutionary Stocks I'd Buy Right Now Without Hesitation ↗

February 07, 2023

These companies are changing their industries.

Via The Motley Fool

IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China

January 31, 2023

From IQVIA

Via Business Wire

IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023

January 25, 2023

From IQVIA

Via Business Wire

Will Investors Notice Exciting Sign On IQVIA Hldgs's Chart? ↗

January 23, 2023

Via Benzinga

Analyst Ratings for IQVIA Hldgs ↗

January 13, 2023

Via Benzinga

Expert Ratings for IQVIA Hldgs ↗

December 06, 2022

Via Benzinga

Where IQVIA Hldgs Stands With Analysts ↗

November 17, 2022

Via Benzinga

Analyst Ratings for IQVIA Hldgs ↗

November 17, 2022

Via Benzinga

Global Market for Medicines to Rise to $1.9 Trillion by 2027, says Report from IQVIA Institute

January 18, 2023

From IQVIA

Via Business Wire

World Wrestling Entertainment To Rally Around 12%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

January 17, 2023

Goldman Sachs boosted the price target for The Wendy's Company (NASDAQ: WEN) from $22 to $25. Goldman Sachs analyst Jared Garber maintained a Neutral rating on the stock. Wendy's shares fell 1.4% to...

Via Benzinga

2 Unstoppable Growth Stocks to Buy in 2023 and Beyond ↗

January 11, 2023

These healthcare companies' revenue and earnings have grown, and they expect more growth.

Via The Motley Fool

Veracyte Stock Showing Market Leadership; Earns 93 RS Rating ↗

December 01, 2022

Veracyte shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

8 Analysts Have This to Say About IQVIA Hldgs ↗

October 27, 2022

IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings within the last quarter:

Via Benzinga

7 Analysts Have This to Say About IQVIA Hldgs ↗

October 06, 2022

Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:

Via Benzinga

Expert Ratings for IQVIA Hldgs ↗

September 12, 2022

Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 ↗

December 06, 2022

Via Benzinga

Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings ↗

November 17, 2022

Piper Sandler boosted the price target on Target Corporation (NYSE: TGT) from $190 to $200. Target shares fell 13.1% to close at $155.47 on Wednesday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022 ↗

November 17, 2022

Upgrades

Via Benzinga

IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel

November 10, 2022

From IQVIA

Via Business Wire

General Electric To Rally Around 14%? Here Are 5 Other Price Target Changes For Thursday ↗

October 27, 2022

Morgan Stanley raised General Electric Company (NYSE: GE) price target from $85 to $88. Morgan Stanley analyst Joshua Pokrzywinski maintained the stock with an Overweight rating. GE shares rose 2.2%...

Via Benzinga

IQVIA: Q3 Earnings Insights ↗

October 26, 2022

IQVIA Hldgs (NYSE:IQV) reported its Q3 earnings results on Wednesday, October 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings IQVIA Hldgs beat estimated...

Via Benzinga

IQVIA Reports Third-Quarter 2022 Results

October 26, 2022

From IQVIA Holdings Inc.

Via Business Wire

Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies ↗

October 25, 2022

Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.

Via Investor's Business Daily

October 25, 2022

Via The Motley Fool

IQVIA CFO Ron Bruehlman to Speak at Credit Suisse Annual Healthcare Conference on November 8, 2022

October 24, 2022

From IQVIA Holdings Inc.

Via Business Wire

Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration With Tasso

October 06, 2022

From IQVIA

Via Business Wire

Tesla To $370? Plus HC Wainwright Slashes PT On This Stock By 67% ↗

October 06, 2022

HC Wainwright & Co. cut KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) price target from $48 to $16. KalVista Pharmaceuticals shares fell 1.8% to $5.06 in pre-market trading.

Via Benzinga

IQVIA to Announce Third-Quarter 2022 Results on October 26, 2022

October 03, 2022

From IQVIA Holdings Inc.

Via Business Wire

IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation

September 28, 2022

From IQVIA

Via Business Wire

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.